XML 20 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
Consolidated Statement of Earnings - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Net Sales $ 40,109 $ 43,653 $ 43,075 Close
Cost of products sold, excluding amortization of intangible assets 17,975 19,142 18,537
Amortization of intangible assets 1,966 2,013 2,047
Research and development 2,741 2,888 2,742
Selling, general and administrative 10,949 11,248 11,324
Total Operating Cost and Expenses 33,631 35,291 34,650 Close
Operating Earnings 6,478 8,362 8,425 Close
Interest expense 637 558 533 Close
Interest income (385) (183) (43) Close
Net foreign exchange (gain) loss 41 2 1 Close
Other (income) expense, net (479) (321) (277) CloseClose
Total Other Income Expenses -186.0 56.0 214.0 0.0 0 Close
Earnings before Taxes 6,664 8,306 8,211 CloseClose
Taxes on Earnings 941 1,373 1,140
Net Earnings $ 5,723 $ 6,933 $ 7,071 Close
Basic earnings per common share (in dollars per share) $ 3.28 $ 3.94 $ 3.97
Diluted earnings per common share (in dollars per share) $ 3.26 $ 3.91 $ 3.94
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) 1,740 1,753 1,775
Dilutive Common Stock Options (in shares) 9 11 14
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) 1,749 1,764 1,789
Outstanding Common Stock Options Having No Dilutive Effect (in shares) 5 3 0